Literature DB >> 29105024

Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients.

Jieling Elaine Chen1, Vivian Weiqun Lou1,2, Hong Jian3, Zhen Zhou3, Meiqiong Yan3, Jingfen Zhu4, Guohong Li4, Yaping He5.   

Abstract

PURPOSE: The purpose of this study is to examine the effect of financial burden, using objective and subjective indicators, on the health-related quality of life (HRQOL) in lung cancer patients.
METHOD: A total of 227 patients diagnosed with lung cancer (from the inpatient unit of the department of internal medicine-chest oncology, in Shanghai Chest Hospital, China) participated in the study. Financial information was measured by direct medical costs, direct nonmedical costs, healthcare-cost-to-income ratio, and perceived financial difficulty. HRQOL was measured using the Functional Assessment of Cancer Therapy-Lung (FACT-L) scale.
FINDINGS: Catastrophic health spending, defined as a healthcare-cost-to-income ratio of more than 40%, was reported in 72.7% of the participants, whereas 37.0% reported that healthcare costs exceeded annual household income. Financial difficulty was perceived in 83.7% of the participants. Patients whose healthcare costs exceeded their annual household income and who perceived financial difficulty reported a clinically meaningful difference in overall HRQOL (> 6 points on the FACT-L) compared with participants without catastrophic health spending or perceived financial difficulty. Healthcare costs did not show a significant effect on HRQOL.
CONCLUSION: Healthcare costs exceeding total annual household income and perceived financial difficulty are associated with poorer HRQOL in lung cancer patients. Subjective indicator of financial burden has a stronger effect on quality of life than objective indicators. IMPLICATION: Health-cost-to-income ratio and perceived financial difficulty can be implied as objective and subjective indicators of financial burden to identify the patients who may need additional assistance. Communication on deciding on cost-effective treatments can be facilitated.

Entities:  

Keywords:  Catastrophic health spending; Financial burden; Lung cancer; Perceived financial difficulty; Quality of life

Mesh:

Year:  2017        PMID: 29105024     DOI: 10.1007/s00520-017-3949-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  27 in total

1.  Impact of the cost of cancer treatment: an internet-based survey.

Authors:  Maurie Markman; Ryan Luce
Journal:  J Oncol Pract       Date:  2010-02-19       Impact factor: 3.840

2.  Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer.

Authors:  Digant Gupta; Christopher G Lis; James F Grutsch
Journal:  Support Care Cancer       Date:  2007-01-23       Impact factor: 3.603

3.  What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.

Authors:  David Cella; David T Eton; Diane L Fairclough; Philip Bonomi; Anne E Heyes; Cheryl Silberman; Michael K Wolf; David H Johnson
Journal:  J Clin Epidemiol       Date:  2002-03       Impact factor: 6.437

4.  Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study.

Authors:  S Yousuf Zafar; Rebecca B McNeil; Catherine M Thomas; Christopher S Lathan; John Z Ayanian; Dawn Provenzale
Journal:  J Oncol Pract       Date:  2014-12-16       Impact factor: 3.840

5.  Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument.

Authors:  D F Cella; A E Bonomi; S R Lloyd; D S Tulsky; E Kaplan; P Bonomi
Journal:  Lung Cancer       Date:  1995-06       Impact factor: 5.705

6.  Association of subjective and objective socioeconomic status with subjective mental health and mental disorders among Japanese men and women.

Authors:  Kaori Honjo; Norito Kawakami; Masao Tsuchiya; Keiko Sakurai
Journal:  Int J Behav Med       Date:  2014-06

Review 7.  Methodology of health-related quality of life analysis in phase III advanced non-small-cell lung cancer clinical trials: a critical review.

Authors:  Frédéric Fiteni; Amélie Anota; Virginie Westeel; Franck Bonnetain
Journal:  BMC Cancer       Date:  2016-02-18       Impact factor: 4.430

8.  The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience.

Authors:  Xiaohui Zeng; Jonathan Karnon; Siying Wang; Bin Wu; Xiaomin Wan; Liubao Peng
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

9.  The financial burden of cancer: estimates from patients undergoing cancer care in a tertiary care hospital.

Authors:  Adnan A Zaidi; Tayyaba Z Ansari; Aziz Khan
Journal:  Int J Equity Health       Date:  2012-10-15

10.  The effect of subjective and objective social class on health-related quality of life: new paradigm using longitudinal analysis.

Authors:  Young Choi; Jae-Hyun Kim; Eun-Cheol Park
Journal:  Health Qual Life Outcomes       Date:  2015-08-08       Impact factor: 3.186

View more
  18 in total

1.  A letter to the editor referencing "Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients".

Authors:  Joohyun Park
Journal:  Support Care Cancer       Date:  2018-05-21       Impact factor: 3.603

2.  Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country.

Authors:  Chuo Yew Ting; Guan Chou Teh; Kong Leong Yu; Haridah Alias; Hui Meng Tan; Li Ping Wong
Journal:  Support Care Cancer       Date:  2019-07-10       Impact factor: 3.603

3.  Impact of objective financial burden and subjective financial distress on spiritual well-being and quality of life among working-age cancer survivors.

Authors:  Danbee Kang; Ka Ryeong Bae; Jihyun Lim; Nayeon Kim; Sungkeun Shim; Sun Seog Kweon; Hwa Jeong Seo; Juhee Cho
Journal:  Support Care Cancer       Date:  2022-02-16       Impact factor: 3.603

4.  Cancer treatment-related financial toxicity experienced by patients in low- and middle-income countries: a scoping review.

Authors:  Suji Udayakumar; Eden Solomon; Wanrudee Isaranuwatchai; Danielle L Rodin; Yoo-Joung Ko; Kelvin K W Chan; Ambica Parmar
Journal:  Support Care Cancer       Date:  2022-03-23       Impact factor: 3.603

5.  Coping, mood and health-related quality of life: a cross-sectional study in Chinese patients with advanced lung cancer.

Authors:  Yaping He; Hong Jian; Meiqiong Yan; Jingfen Zhu; Guohong Li; Vivian W Q Lou; Jieling Chen
Journal:  BMJ Open       Date:  2019-05-05       Impact factor: 2.692

6.  Family Caregivers' Involvement in Caring with Cancer and their Quality of Life.

Authors:  Sevcan Toptas Kilic; Fatma Oz
Journal:  Asian Pac J Cancer Prev       Date:  2019-06-01

7.  Factors associated with quality of life of adult patients with acute leukemia and their family caregivers in China: a cross-sectional study.

Authors:  Chunfeng Wang; Jie Yan; Jingyi Chen; Ying Wang; Ying Chun Lin; Rong Hu; Yong Wu
Journal:  Health Qual Life Outcomes       Date:  2020-01-07       Impact factor: 3.186

8.  Quantifying the Effect of Financial Burden on Health-Related Quality of Life among Patients with Non-Hodgkin's Lymphomas.

Authors:  Richard Huan Xu; Eliza Lai-Yi Wong; Yi Su; Hongyu Zhang; Wei Zhang; Dong Dong
Journal:  Cancers (Basel)       Date:  2020-11-11       Impact factor: 6.639

9.  Socio-Economic Burden of Myocardial Infarction Among Cancer Patients.

Authors:  Avirup Guha; Amit Kumar Dey; Sadeer Al-Kindi; P Elliott Miller; Arjun K Ghosh; Amitava Banerjee; Juan Lopez-Mattei; Nihar R Desai; Brijesh Patel; Guilherme H Oliveira; Marcos de Lima; Michael Fradley; Daniel Addison
Journal:  Am J Cardiol       Date:  2020-11-18       Impact factor: 2.778

10.  Assessing the Relationship between Socio-demographic, Clinical Profile and Financial Toxicity: Evidence from Cancer Survivors in Sarawak.

Authors:  Shee-Ling Yap; Shirly Siew-Ling Wong; Keng-Sheng Chew; Jerome Swee-Hui Kueh; Ke-Lin Siew
Journal:  Asian Pac J Cancer Prev       Date:  2020-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.